Heart News and Research

RSS

New radiotherapy system benefits high-risk patients

A new radiotherapy system that combines high-tech imaging with precision tumor-targeting capability is helping cancer specialists at Stony Brook University Medical Center treat patients.

10 Dec 2007

Researchers photograph cystic fibrosis protein interaction

New microscopic pictures show the first-ever physical evidence of interaction between two proteins involved in Cystic Fibrosis (CF) disease.

10 Dec 2007

Winter flu doubles the risk of heart attacks and stroke

Scientists in Britain say a dose of winter infections such flu can double the risk of heart attacks and strokes.

9 Dec 2007

Obesity all set to make future generations fatter and sicker

Researchers from the United States and Denmark are warning that unless steps are taken to reverse the growth in the number of obese children, future generations will be both fatter and sicker than their parents.

6 Dec 2007

Closest look ever at native human tissue

Seeing proteins in their natural environment and interactions inside cells has been a long-standing goal.

5 Dec 2007

Myocor receives trial approval for percutaneously implanted iCoapsys system

Myocor, Inc. announced that the U.S. Food and Drug Administration has granted conditional approval of the Valvular and Ventricular Improvement Via iCoapsys Delivery (VIVID) feasibility study.

5 Dec 2007

Implanting embryonic cardiac cells prevents arrhythmias

When researchers at Cornell, the University of Bonn and the University of Pittsburgh transplanted living embryonic heart cells into cardiac tissue of mice that had suffered heart attacks, the mice became resistant to cardiac arrhythmias, thereby avoiding one of the most dangerous and fatal consequences of heart attacks.

5 Dec 2007

Honey a cheaper and more effective treatment for children's coughs than cough medicine

Experts in the United States say when it comes to children's coughs, natural honey offers a cheaper and more effective alternative to expensive over-the-counter cough medicines.

5 Dec 2007

Popular diabetes drug Avandia linked to osteoporosis

UK fertility regulator wants fewer IVF twin births in order to save lives

The fertility regulator in the UK, the Human Fertilisation and Embryology Authority (HFEA) has called for a reduction in the number of twin births from IVF.

5 Dec 2007

Being fit more important than being fat when it comes to a longer life

The latest research is saying that fitness may be more important when it comes to living longer, than being overweight.

5 Dec 2007

Re-engineered Gleevec reduces heart risks

Using a new bottom-up approach for rational drug design, researchers at Rice University and the University of Texas M. D. Anderson Cancer Center have reengineered the powerful anticancer drug imatinib - best known by its brand name Gleevec - to more specifically target one type of cancer while potentially curbing a rare life-threatening cardiotoxic side effect.

4 Dec 2007

Simple two-in-one test signals high risk after a heart attack

Everyone loves a two-fer, but a two-in-one heart test that has the potential to save lives is the real deal.

4 Dec 2007

Quality-improvement initiatives lead to progress in diabetes care

Two major initiatives designed to improve primary care treatment of type 2 diabetes have yielded significant benefits in largely minority, disadvantaged populations, according to a pair of studies in the December issue of Medical Care.

4 Dec 2007

Modified form of imatinib becomes more specific

Imatinib (marketed as Gleevec in the US and Glivec in Europe and Australia) is used to treat various cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs).

4 Dec 2007

Diet low in carbohydrates reduces inflammation and blood saturated fat in metabolic syndrome

Metabolic syndrome is a condition afflicting one quarter to one third of adult men and women and is an established pre-cursor to diabetes, coronary heart disease, and other serious illnesses.

4 Dec 2007

Genes discovered that protect against heart damage from chemotherapy

A series of genes that protect cells from the powerful, common chemotherapeutic agent doxorubicin has been identified by researchers working to understand how the drug also can destroy the heart.

4 Dec 2007

Approval of Diovan (valsartan) in U.S. for hypertension in children and adolescents

Diovan (valsartan), an angiotensin receptor blocker or ARB, has been approved following a priority review by the U.S. Food and Drug Administration (FDA) for the treatment of high blood pressure in children and adolescents ages six to 16.

4 Dec 2007

Hydrogen sulfide provides clues to a longer life

Hydrogen sulfide, or H2S, the chemical that gives rotten eggs their sulfurous stench - and the same compound that researchers at Fred Hutchinson Cancer Research Center successfully have used to put mice into a state of reversible metabolic hibernation - has now been shown to significantly increase life span and heat tolerance in the nematode worm, or C. elegans.

4 Dec 2007

Cold Spring Harbor Protocols features innovative methods for embryology research

Two methods that permit scientists to examine critical stages in early embryogenesis are featured in this month's release of Cold Spring Harbor Protocols.

4 Dec 2007